A comparative study of efficacy of drinking water on declining the incidence of nausea after administration of Teriparatide acetate
Not Applicable
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000037146
- Lead Sponsor
- Kansai medical university, Kori Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with contraindication for the administration of teriparatide acetate 2)Patients who cannot drink a water orally 3)Patients who already had finished 104 times of the administration of teriparatide acetate, or were administrated several times 4)Patients who refused to participate this study by sufficient information 5)Other patients who are judged inappropriate to participate this study by director of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcomes are the incidence of nausea after the administration of Teriparatide acetate.
- Secondary Outcome Measures
Name Time Method The secondary outcomes are the change of blood pressures immediately after administration of Teriparatide acetate and persistence rate of the administration.